Clare E. Collins

Papers

2

Total Citations

346

H-Index

2

About

Clare E. Collins is a leading urologic oncologist whose research focuses on optimizing surgical outcomes for patients with bladder cancer, particularly through the comparative evaluation of robot-assisted and open radical cystectomy. Her landmark work, published in *JAMA* in 2022, demonstrated that robot-assisted radical cystectomy with intracorporeal urinary diversion does not significantly reduce 90-day morbidity or mortality compared to open surgery—a finding that has garnered over 320 citations and reshaped clinical decision-making. Collins further advanced the field with a 2023 cost-effectiveness analysis, showing that while robotic surgery offers comparable clinical outcomes, its higher costs raise important questions about value-based care. Her contributions provide critical evidence for surgeons and policymakers navigating the adoption of expensive surgical technologies. With a career dedicated to rigorous comparative effectiveness research, Collins has become a key voice in urologic oncology, helping to balance innovation with practical, patient-centered outcomes. Her work continues to influence surgical guidelines and healthcare resource allocation in bladder cancer treatment.

Research Focus

Key Achievements

2
H-Index
2
Papers
346
Total Citations
173
Avg Citations/Paper
🏆 Most Cited Paper
Effect of Robot-Assisted Radical Cystectomy With Intracorporeal Urinary Diversion vs Open Radical Cystectomy on 90-Day Morbidity and Mortality Among Patients With Bladder Cancer
320 citations · 2022
📈 Most Prolific Year: 2022 (1 Papers)
🤝 Key Collaborators: 70

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago